Abstract
The medical treatment of seizures in newborn babies has remained unchanged for decades. In the past decade, experts in neurology, neonatology, and epilepsy have met on several occasions to discuss the urgent need to study novel anti-seizure agents in newborns;1,2 however, since 1999, despite many recommendations, no group has been able to successfully undertake an efficacy trial to assess treatment of electrographic seizures in neonates.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have